Nitin K.Sethi, New York-Presbyterian Hospital, New Yorksethinitinmd@hotmail.com
Submitted June 21, 2014
I read with interest Raphaelson and Brown's article on sleep
medicine practice adaptations.1 As a neurologist
with subspecialty certification in sleep medicine, I see
patients in my hospital's sleep center 2 half-days a week.
Recent payment policy changes by Medicare and commercial
medical insurance companies have made it increasingly
difficult to get an in-laboratory (attended) sleep study
approved for the sleep apnea patient who has no other
cardiovascular comorbidities. Even if I strongly suspect
moderate to severe grade of sleep-disordered breathing in
that patient, I have stopped requesting peer-to-peer review
since I know that my peer on the other end of the line has
his or her hands bound. The answer is going to be "no and
request denied" even though he or she may acknowledge
(off
the record) that I have a valid case. So it is not uncommon
for me to order a home sleep study only to find it
substandard. Then I am forced to either treat my patient on
the basis of that or to request an in-laboratory study and
hope to get it approved this time around. Fraudulent
practices in the past by some should not result in radical
policy changes that apply to all physicians and are
detrimental to our patients. The pendulum has swung from in-
laboratory sleep study for any and every indication to in-laboratory study only for the patient with documented
cardiovascular comorbidities. I hope somewhere between these
2 extremes there is a middle ground where common sense
prevails.
Disclosures: N. Sethi serves as Associate Editor for The
Eastern Journal of Medicine.
Reference
1. Raphaelson M, Brown DB. Sleep medicine practice
adaptations. Neurol Clin Pract 2014;4:63-70.
Disclosures: N. Sethi serves as Associate Editor for The Eastern Journal of Medicine.
Reference
1. Raphaelson M, Brown DB. Sleep medicine practice adaptations. Neurol Clin Pract 2014;4:63-70.